Traders assign a 48.5% implied probability to a cumulative flu hospitalization rate of 80–85 per 100,000 population by week 12 (late March) 2026, reflecting consensus on a moderate influenza season amid historical baselines and early 2024–25 surveillance data from the CDC. Current season activity remains low, with cumulative rates at just 1.4 per 100,000 as of early November per latest FluView reports, dominated by A(H3N2) and A(H1N1)pdm09 strains showing reasonable vaccine match (estimated 42% effectiveness). This tempers expectations below severe seasons' peaks (often 120+ per 100k by week 12), while waning population immunity and potential viral evolution keep upside risk for 90–95 (20.5%) or higher. Key upcoming CDC weekly updates through winter will refine epidemiological trajectories and transmission dynamics.
Experimental AI-generated summary referencing Polymarket data · UpdatedFlu Hospitalization Rate Week 12, 2026?
Flu Hospitalization Rate Week 12, 2026?
90–95 39%
95+ 33%
<75 19.1%
85–90 4.0%
<75
19%
75–80
2%
80–85
52%
85–90
4%
90–95
21%
95+
33%
90–95 39%
95+ 33%
<75 19.1%
85–90 4.0%
<75
19%
75–80
2%
80–85
52%
85–90
4%
90–95
21%
95+
33%
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Market Opened: Mar 27, 2026, 11:13 AM ET
Resolver
0x69c47De9D...If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Resolver
0x69c47De9D...Traders assign a 48.5% implied probability to a cumulative flu hospitalization rate of 80–85 per 100,000 population by week 12 (late March) 2026, reflecting consensus on a moderate influenza season amid historical baselines and early 2024–25 surveillance data from the CDC. Current season activity remains low, with cumulative rates at just 1.4 per 100,000 as of early November per latest FluView reports, dominated by A(H3N2) and A(H1N1)pdm09 strains showing reasonable vaccine match (estimated 42% effectiveness). This tempers expectations below severe seasons' peaks (often 120+ per 100k by week 12), while waning population immunity and potential viral evolution keep upside risk for 90–95 (20.5%) or higher. Key upcoming CDC weekly updates through winter will refine epidemiological trajectories and transmission dynamics.
Experimental AI-generated summary referencing Polymarket data · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions